鄭 鴻琳

Medicine & Life Sciences

1. Urinary Bladder Neoplasms 100%
2. Transitional Cell Carcinoma 91%
3. Urinary Bladder 87%
4. Urinary Tract 61%
5. Carcinoma 58%
6. Neoplasms 55%
7. Prostatic Hyperplasia 54%
8. rice bran saccharide 51%
9. ErbB Receptors 49%
10. Fournier Gangrene 30%
11. Kidney 30%
12. Transurethral Resection of Prostate 28%
13. Plasma Cell Granuloma 27%
14. Urine 27%
15. Carcinogenesis 25%
16. Survival 23%
17. Loss of Heterozygosity 19%
18. Renal Cell Carcinoma 18%
19. RON protein 17%
20. tissue polypeptide specific antigen 17%
21. Hydronephrosis 17%
22. silodosin 16%
23. Isoflavones 16%
24. Ureteral Neoplasms 16%
25. Urothelium 15%
26. Receptor Protein-Tyrosine Kinases 15%
27. Biomarkers 15%
28. Biostatistics 15%
29. Hematuria 15%
30. Vesico-Ureteral Reflux 14%
31. Laser Coagulation 14%
32. Tamsulosin 14%
33. Prostate-Specific Antigen 14%
34. Nocturnal Enuresis 14%
35. Quality of Life 14%
36. Myofibroblasts 14%
37. Enuresis 13%
38. Prostatic Neoplasms 13%
39. DNA 12%
40. Therapeutics 12%
41. Creatinine 12%
42. src Homology Domains 11%